MNOV · Medicinova Inc · Executive Compensation

$1.36 -0.04 (-2.86%) At close · Oct 20

Market Cap

$68.91M

49.22M

Volume · Oct 20 37.12K Avg daily vol (3M) 322.6K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yuichi Iwaki	M.D., Ph.D. President and Chief Executive Officer	$657,377	—	—	$729,645	$328,689	$21,000	$1,736,711
Kazuko Matsuda	M.D., Ph.D., MPH Senior Vice President, Chief Medical Officer	$514,422	—	—	$589,888	$205,769	$21,000	$1,331,079
David H. Crean	Chief Business Officer	$120,000	—	—	—	—	—	$120,000

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yuichi Iwaki	M.D., Ph.D. President and Chief Executive Officer	$657,377	—	—	$401,471	$328,689	$20,700	$1,408,237
Kazuko Matsuda	M.D., Ph.D., MPH Chief Medical Officer	$505,422	—	—	$301,103	$176,898	$20,700	$1,004,123
Geoffrey O’Brien	J.D./M.B.A. Former Vice President	$155,756	—	—	—	—	$14,910	$170,666
David H. Crean	Chief Business Officer	$99,000	—	—	—	—	—	$99,000

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yuichi Iwaki	M.D., Ph.D. President and Chief Executive Officer	$657,377	—	—	$481,050	$230,082	$19,800	$1,388,309
Kazuko Matsuda	M.D., Ph.D., MPH Chief Medical Officer	$505,422	—	—	$360,788	$123,828	$19,800	$1,009,838
Geoffrey O’Brien	J.D./M.B.A. Former Vice President	$378,579	—	—	$192,420	$92,716	$19,800	$683,515

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yuichi Iwaki	M.D., Ph.D. President and Chief Executive Officer	$620,167	—	—	$359,594	$294,579	$18,300	$1,292,640
Kazuko Matsuda	M.D., Ph.D. Chief Medical Officer	$476,814	—	—	$228,833	$158,540	$18,300	$882,487
Geoffrey O’Brien	J.D./M.B.A. Vice President	$357,150	—	—	$117,685	$118,752	$18,300	$611,887

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yuichi Iwaki	M.D., Ph.D. President and Chief Executive Officer	$596,315	—	—	$1,980,330	$163,987	$17,400	$2,758,032
Kazuko Matsuda	M.D., Ph.D. Chief Medical Officer	$458,474	—	—	$1,260,210	$88,256	$17,400	$1,824,340
Geoffrey O’Brien	J.D./M.B.A. Vice President	$343,413	—	—	$648,108	$66,107	$17,400	$1,075,028

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yuichi Iwaki	M.D., Ph.D. President and Chief Executive Officer	$586,924	—	—	$2,098,085	$264,116	$17,100	$2,966,225
Kazuko Matsuda	M.D., Ph.D. Chief Medical Officer	$451,254	—	—	$1,239,778	$157,939	$17,100	$1,866,071
Geoffrey O’Brien	J.D./M.B.A. Vice President	$338,005	—	—	$839,234	$53,236	$17,100	$1,247,575

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yuichi Iwaki	M.D., Ph.D. President and Chief Executive Officer	$572,051	—	—	$2,958,518	$214,519	$16,800	$3,761,888
Kazuko Matsuda	M.D., Ph.D. Chief Medical Officer	$439,819	—	—	$1,748,215	$131,946	$16,800	$2,336,780
Geoffrey O’Brien	J.D./M.B.A. Vice President	$329,440	—	—	$1,183,407	$98,832	$16,800	$1,628,479

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yuichi Iwaki	M.D., Ph.D. President and Chief Executive Officer	$551,108	—	—	$1,913,699	$371,998	$16,500	$2,853,305
Kazuko Matsuda	M.D., Ph.D. Chief Medical Officer	$394,816	—	—	$1,201,152	$213,201	$16,500	$1,825,669
Geoffrey O’Brien	J.D./M.B.A. Vice President	$307,746	—	—	$834,699	$166,183	$16,500	$1,325,128

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Yuichi Iwaki	M.D., Ph.D. President and Chief and Executive Officer ^^	$533,503	—	—	$1,740,825	$266,751	$16,200	$1,936,263
Kazuko Matsuda	M.D., Ph.D. Chief Medical Officer ^^	$382,203	—	—	$1,083,180	$171,992	$8,279	$1,645,654
Geoffrey O’Brien	J.D./M.B.A. Vice President	$297,914	—	—	$773,700	$128,103	$16,200	$1,215,917

Executive changes

Person	Role	Change	Effective	Filed
Geoffrey O’Brien	Vice President	Resigned	2024-04-02	2024-04-01
Nicole Lemerond	member of the Board	Appointed	2023-08-04	2023-08-07

Leadership

Key facts CIK 1226616 CUSIP 58468P206 13F (30d) 1 filings 1 filers Visit website Investor relations